WELCOME

BIOSTROKE offers a unique platform to advance biomarker science in stroke care and foster interdisciplinary collaboration between experts in stroke biomarker research, cardiovascular medicine, and neuroscience. Bringing together 120 participants, the meeting will facilitate in-depth scientific exchange on the most pressing, unsolved challenges in clinical decision-making with sessions* across the stroke care continuum – from prehospital management to secondary prevention and long-term recovery. The program features talks by internationally recognized leaders, alongside presentations selected from submitted abstracts. The format prioritizes open discussion and informal interactions among scientists of all career levels.

BIOSTROKE is endorsed by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT). CME/CPD accreditation is currently in process. 

Participation requires registration* via this website and is on a first-come, first-served basis.

We look forward to welcoming you in Munich in February 2025!

John McCabe, Johanna Ospel, Steffen Tiedt

ORGANIZING TEAM

John McCabe

University College
Dublin, Ireland

Johanna Ospel

University of Calgary, Canada

Steffen Tiedt

Institute for Stroke &
Dementia Research, LMU Hospital Munich, Germany

PHOTOS FROM THE EVENT 2026

Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image
Image without a title
Image

BIOSTROKE Meeting 2026

The 2nd BIOSTROKE meeting took place at Hohenkammer castle from February 23 to 25, 2026. 

We thank all speakers, poster presenters, and participants for their contributions and the very fruitful, interesting discussions. We look forward to the strong science built on BIOSTROKE collaborations. Thanks to our funders (DFG, UoC, ISCBFM) and sponsors (Merck, CSL, Quanterix) for their support!

We look forward to welcoming you all again in 2027!

BIOSTROKE 2026 was endorsed by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT). CME/CPD accreditation is currently in process. 

PROGRAM

Download Program 2026 – PDF

VENUE

Hohenkammer Castle
(Schloss Hohenkammer, 40 km from Munich city center)
Schlossstrasse 18 – 25

85411 Hohenkammer, Germany

Research

*Programm, Registration links and Abstract Submission will be accessible soon on this website!